INTERNATIONAL PATENT: NXI THERAPEUTICS AG, UNIVERSITAT BASEL FILES APPLICATION FOR "4-(HETERO)ARYL-7-(HETERO)ARYL-2-METHYL-5-OXO-1,4,5,6,7,8-HEXAHYDROQUINOLINE-3-CA RBOXYLIC ACID DERIVATIVES AS CORONIN-1 MODULATORS"

GENEVA, Oct. 13 -- NXI THERAPEUTICS AG (Spitalstrasse 414056 Basel), UNIVERSITAT BASEL (Vizerektorat ForschungPetersgraben 354001 Basel) filed a patent application (PCT/EP2025/059194) for "4-(HETERO)ARYL-7-(HETERO)ARYL-2-METHYL-5-OXO-1,4,5,6,7,8-HEXAHYDROQUINOLINE-3-CA RBOXYLIC ACID DERIVATIVES AS CORONIN-1 MODULATORS" on Apr 03, 2025. With publication no. WO/2025/210193, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JAYACHANDRAN, Rajesh (c/o NXI Therapeutics AGSpitalstrasse 414056 Basel), PIETERS, Jean (c/o Universitat...